OneSource Specialty Pharma Ltd reports Q3 FY26 revenue of ₹2.9 billion, EBITDA declines amid approval delays
● Jan 24, 2026
OneSource Specialty Pharma Ltd (BSE: 544292 / NSE: ONESOURCE) reported consolidated revenue of ₹2.9 billion for the quarter ended December...
